ANJİOÖDEM

Anjioödem (AÖ) genellikle subkutan dokuda belirginleşen, ayrıca solunum ve gastrointestinalsistem submukozal tabakasında geçici, lokalize ödem ile karakterize bir hastalıktır. AÖ, vücudun herhangi bir yerinde görülse de en çok ekstremiteler, yüz, genital organlar, hava yolları vegastrointestinal sistemde görülür. AÖ tanısı hızlı bir ön değerlendirme, ayrıntılı anamnez ve fizikmuayene ile konulur. Alerjik AÖ ürtiker ile ilişkilidir. Akut atakta morbidite ve olası mortaliteyiazaltmak için hastaya en erken zamanda müdahele edilmelidir. Non-alerjik AÖ akut tedavisindeC1inhibitör preparatları tercih edilir

Angioedema

Angioedema (AO) is a disorder which is usually seen in the subcutaneous tissue characterized by edema, which is temporarily localized in the submucosal layer in the respiratory and gastrointestinal system. Angioedema occurs most often in the extremities, the face, the genital organs, the airways and the gastrointestinal tract, although it is seen anywhere in the body. The diagnosis of angioedema is made by a quick preliminary evaluation, detailed history and physical examination. Allergic AO is associated with urticaria. The patient should be intervened at the earliest time to reduce morbidity and possible mortality in an acute attack. C1-inhibitor preparations are preferred in the acute treatment of non-allergy AO.

___

  • 1. Wilkerson RG. Angioedema in the emergency department: an evidence-based review. Emerg Med Pract.2012;14(11):1-21.
  • 2. Lewis LM. Angioedema: etiology, pathophysiology, current and emerging therapies.J Emerg Med.2013;45(5):789-796.
  • 3. Gülbahar O, Gelincik A, Sin A, Güleç M, Yılmaz M, Gökmen NM. Herediter anjiyoödem. Asthma Allergy Immunol. 2010;8:125-138.
  • 4. Kaplan AP, Greaves MW. Angioedema. Am Acad Dermatol. 2005;53(3):373-388.
  • 5. Wade J, Barkley TW. Hereditary Angioedema: An emergency nursing perspective. J Emerg Nurs. 2015; 41(5):391-395.
  • 6. Inomata N.Recent advances in drug-ınducedangioedema.Allergol Int. 2012;61(4):545-557.
  • 7. Göncü EK, Aktan Ş, Atakan N, Başkan EB, Erdem T, Koca R, Şavk E, Taşkapan O, Utaş S. Türkiye Ürtiker Tanı ve Tedavi Kılavuzu-2016. Turkderm - Arch Turk Dermatol Venerology. 2016;50:82-98
  • 8. Moellman JJ, Bernstein JA, Lindsell C, Banerji A, Busse PJ, Camargo CA Jr.A consensus parameter for the evaluation and management of angioedema in the emergency department.Acad Emerg Med. 2014;21(4):469-484.
  • 9. Vatansever S, Başkan EB. Ürtiker ve Anjiyoödem. In Sarıcaoğlu H, Başkan EB, eds. Dermatoloji. 1st ed. İstanbul, Nobel Tıp Kitabevleri, 2012. p.261-276.
  • 10. Moellman JJ, Bernstein JA. Diagnosis and management of hereditary angioedema: an emergency medicine perspective.J Emerg Med. 2012;43(2):391-400.
  • 11. Gakhal MS, Marcotte GV. Hereditary angioedema: imaging manifestations and clinical management. Emerg Radiol. 2015;22(1):83-90.
  • 12. Aydemir HE, Gürkan A. Eritem ve Ürtiker. In Aydemir HE, eds. Andrews’ Deri Hastalıkları Klinik Dermatoloji. 10th ed. İstanbul: İstanbul Tıp Kitabevi, 2008. p.149-156.
  • 13. Jaiganesh T, Wiese M, Hollingsworth J, Hughan C, Kamara M, Wood P, Bethune C. Acute angioedema: recognition and management in the emergency department.Eur J Emerg Med. 2013;20(1):10-17.
  • 14. Cicardi M, Bellis P, Bertazzoni G, Cancian M, Chiesa M, Cremonesi P. Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts.Intern Emerg Med. 2014; 9(1):85-92.
  • 15. Satkiene D, Kavoliuniene A, Petrauskiene I, Sirvyte R. Tongue angioedema associated with angiotensin-converting enzyme inhibitor (diagnosis, differential diagnosis, treatment). Medicina (Kaunas). 2003;39(6):570-573.
  • 16. Chiu AG, Krowiak EJ, Deeb ZE: Angioedema associated with angiotensin II receptor antagonists: challenging our knowledge of angioedema and its etiology. Laryngoscope. 2001;111(10);1729- 1731.
  • 17. Bernstein JA, Moellman J. Emerging concepts in the diagnosis and treatment of patients with undifferentiated angioedema.Int J Emerg Med. 2012;5(1):39.
  • 18. Bork K, Meng G, Staubach P, Hardt J. Hereditary angioedema: new findings concerning symptoms, affected organs, and course. Am J Med. 2006;119(3):267-274.
  • 19. Cicardi M, Zanichelli A. Acquired angioedema.Allergy Asthma Clin Immunol. 2010;6(1):14.
  • 20. Kılıç G, Güler N. Alerjinin Bilinmez Sorununa Tanısal Yaklaşım: Kronik Ürtiker ve Anjioödem.Çocuk Dergisi. 2009;9(2):68-75.
  • 21. Riguzzi C, Losonczy L, Teismann N, Herring AA, Nagdev A. Gastrointestinal manifestations of hereditary angioedema diagnosed by ultrasound in the emergency department.West J Emerg Med. 2014;15(7):816-818.
  • 22. Bhardwaj N, Craig TJ.Treatment of hereditary angioedema: a review (CME). Transfusion.2014;54(11):2989-2996.
  • 23. Özçeker D, Tamay Z, Çitak A, Bulut M, Güler N.Çocuklarda Karın Ağrısının Nadir Bir Nedeni: Herediter Anjioödem. HasekiTıp Bülteni. 2015;53:98-100.
  • 24. Bernstein JA. Hereditary angioedema: a current stateof- the-art review, VIII: a current status of emerging therapies. Ann Allergy Asthma Immunol. 2008;100(1):41-46.
  • 25. Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W.Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant). J Allergy Clin Immunol. 2007;119(6):1497-1503.
  • 26. Frank MM. Hereditary angioedema: a half century of progress. J Allergy Clin Immunol. 2004;114(3):626-628.
  • 27. Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W, Zingale L, et al. Canadian 2003 international consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol. 2004;114(3):629-637.
  • 28. Maves KK, Weiler JM. Tonsillectomy in a patient with hereditary angioedema after prophylaxis with C1 inhibitor concentrate. Ann Allergy. 1994;73(5):435-438.
  • 29. Crook D, Sidhu M, Seed M, O'Donnell M, Stevenson JC. Lipoprotein Lp(a) levels are reduced by danazol, an anabolic steroid. Atherosclerosis. 1992;92(1):41-47.
  • 30. Szeplaki G, Varga L, Valentin S, Kleiber M, Karadi I, Romics L, et al. Adverse effects of danazol prophylaxis on the lipid profiles of patients with hereditary angioedema. J Allergy Clin Immunol. 2005;115(4):864-869.
Bozok Tıp Dergisi-Cover
  • ISSN: 2146-4006
  • Yayın Aralığı: Yılda 4 Sayı
  • Başlangıç: 2015
  • Yayıncı: Bozok Üniversitesi
Sayıdaki Diğer Makaleler

TRANSTİBİAL VE TRANSFEMORAL AMPUTELERİN DENGE VE DÜŞME DÜZEYLERİNİN KARŞILAŞTIRILMASI Comparison of Balance and Falling Levels of Transtibial and Transfemoral Amputees

Abdulkadir AYDIN, Ramazan ATİÇ

BİR İLDE 40-69 YAŞ KADINLARDA MEME KANSERİ TARAMALARININ DEĞERLENDİRİLMESİ

İrem AKOVA, Hayriye TÜRKOĞLU, Öznur HASDEMİR

SAĞLIĞA İLİŞKİN RİSKLERİN DEĞERLENDİRİLMESİNDE VÜCUT KÜTLE İNDEKSİNİN KULLANIMI YETERLİ MİDİR? Is the Use of Body Mass Index Sufficient to Assess Health Risks?

Aslı DEVRİM, Pelin BİLGİÇ

TRAVMALI HASTALARDA KANADA SERVİKAL OMURGA KURALLARI VE NEXUS DÜŞÜK RİSK KRİTERLERİNİN GEÇERLİLİĞİ

Bora KAYA, Özlem GÜNEYSEL, Haldun AKOĞLU, Erkman SANRI

VENTRAL HERNİ ONARIMINDA POLİPROPİLEN VE SİLİKON KAPLI POLİPROPİLEN YAMANIN RAT MODELİNDE KARŞILAŞTIRILMASI

Arif Hakan DEMİREL, Berkay KÜÇÜK, Muzaffer ÇAYDERE, Salih TUNCAL, Yılmaz ÜNAL

İSKİOFEMORAL SIKIŞMA SENDROMU AÇISINDAN İSKİOFEMORAL VE QUADRATUS FEMORİS MESAFELERİNİN MANYETİK REZONANS GÖRÜNTÜLEME İLE DEĞERLENDİRİLMESİ Evaluation of Ischiofemoral and Quadratus Femoris Spaces by Magnetic Resonance Imaging in terms of Ischiofemoral Impingement

Kutsi TUNCER, Gökhan POLAT, Ahmet Emre PAKSOY

NÖROLOJİK HASTALIĞI OLAN BİREYLERİN KRONİK HASTALIK BAKIMINA İLİŞKİN DEĞERLENDİRMELERİ

Tülay KARS FERTELLİ, Fatma ÖZKAN TUNCAY

SAĞLIK HİZMETLERİ MESLEK YÜKSEKOKULU ÖĞRENCİLERİNİN GENİTAL HİJYEN DAVRANIŞLARININ İNCELENMESİ

Aynur CİN, Birgül TUNCAY, Hatice DEMİRAĞ, Sevilay HİNDİSTAN

İNLET PATCH SIKLIĞI ve KLİNİK ÖNEMİ

Ergin ARSLAN, Gamze TALİH, Betül AYTEKİN, Soykan DİNÇ, Tutkun TALİH

TOTAL DİZ ARTROPLASTİSİNDE KORKU VE ANKSİYETENİN YAŞAM KALİTE VE İŞLEVSEL SONUÇLARA ETKİSİ Effect of Fear and Anxiety on Quality of Life and Functional Results in Total Knee Arthroplasty

Murat AŞÇI